Orion Infusion Limited announcements
236 Dhaka Stock Exchange announcements for Orion Infusion Limited (ORIONINFU) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2011 (16).
- Following the change of denomination, normal trading of the shares of the Company will resume on 04.12.2011 after record
Following the change of denomination, normal trading of the shares of the Company will resume on 04.12.2011 after record date with new face value of Tk. 10.00 per share, market lot of 200 shares and adjusted open price of Tk. 53.40 per share.
- Normal trading of the shares of the Company will resume on 24.11.2011 after record date.
Normal trading of the shares of the Company will resume on 24.11.2011 after record date.
- Trading of the shares of the Company will remain suspended on record date i.e., 23.11.2011.
Trading of the shares of the Company will remain suspended on record date i.e., 23.11.2011.
- Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be
Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per Spot settlement cycle with cum benefit from 20.11.11 to 22.11.11. Trading of the shares of the Company will remain suspended on record date i.e., 23.11.11.
- (Q1): As per un-audited quarterly accounts for the 1st quarter ended on 30th September 2011 (July'11 to Sep'11), the Com
(Q1): As per un-audited quarterly accounts for the 1st quarter ended on 30th September 2011 (July'11 to Sep'11), the Company has reported net profit of Tk. 10.36 million with EPS of Tk. 5.09 as against Tk. 9.12 million and Tk. 4.48 respectively for the same period of the previous year.
- The Board of Directors has recommended cash dividend @ 15% for the year ended on June 30, 2011. Date of AGM: 18.12.2011,
The Board of Directors has recommended cash dividend @ 15% for the year ended on June 30, 2011. Date of AGM: 18.12.2011, Time: 9:30 AM, Venue: Officers Club, 26 Baily Road, Dhaka. Record date: 23.11.2011. The Company has also reported EPS of Tk. 16.13, NAV per share of Tk. 93.23 and NOCFPS of Tk. 11.36 for the year ended on June 30, 2011.
- There will be no price limit on the trading of the shares of the Company today (13.11.2011) following its corporate decl
There will be no price limit on the trading of the shares of the Company today (13.11.2011) following its corporate declaration.
- Normal trading of the shares of the Company will resume on 13.11.11 after record date for EGM.
Normal trading of the shares of the Company will resume on 13.11.11 after record date for EGM.
- Trading of the shares of the Company will remain suspended on record date i.e., 03.11.11 for EGM.
Trading of the shares of the Company will remain suspended on record date i.e., 03.11.11 for EGM.
- Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be
Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per Spot settlement cycle from 31.10.11 to 02.11.11. Trading of the shares of the Company will remain suspended on record date i.e., 03.11.11 for EGM.
- The Company has informed that the Board of Directors of the Company has decided to change the denomination of face value
The Company has informed that the Board of Directors of the Company has decided to change the denomination of face value of shares from Tk. 100.00 to Tk. 10.00 each and market lot from 20 to 100 shares as well as to amend the relevant clauses of the Memorandum and Articles of Association of the Company subject to the approval of shareholders in the EGM and Regulatory Authorities. Date of EGM: 26.11.2011, Time: 10:30 AM, Venue: 36, Shahid Tajuddin Ahmed Sarani, Tejgaon, Dhaka-1208. Record date for EGM: 03.11.2011.
- In response to a DSE query, the company has informed that there is no undisclosed price sensitive information of the com
In response to a DSE query, the company has informed that there is no undisclosed price sensitive information of the company for recent unusual price hike.
- (Q3): As per un-audited quarterly accounts for the 3rd quarter ended on 31st March 2011 (Jan'11 to March'11), the compan
(Q3): As per un-audited quarterly accounts for the 3rd quarter ended on 31st March 2011 (Jan'11 to March'11), the company has reported net profit before tax of Tk. 7.19 million with EPS of Tk. 3.53 as against Tk. 5.55 million and Tk. 2.72 respectively for the same period of the previous year. Whereas net profit before tax was Tk. 28.84 million with EPS of Tk. 14.17 for the period of nine months (July'10 to March'11) ended on 31.03.2011 as against Tk. 22.57 million and Tk.11.08 respectively for the same period of the previous year. Accumulated profit/(loss) of the company was Tk. (163.14) million as on 31.03.11.
- In response to a DSE query dated 03.04.11, the company has informed that there is no undisclosed price sensitive informa
In response to a DSE query dated 03.04.11, the company has informed that there is no undisclosed price sensitive information of the company for recent unusual price hike.
- (H/Y): As per un-audited half yearly accounts as on 31.12.10 (July' 10 to Dec' 10), the company has reported net profit
(H/Y): As per un-audited half yearly accounts as on 31.12.10 (July' 10 to Dec' 10), the company has reported net profit of Tk. 21.66 million with EPS of Tk. 10.64 as against Tk. 16.63 million and Tk. 8.17 respectively for the same period of the previous year. Accumulated profit/(loss) of the company was Tk. (170.33) million as on 31.12.10.
- (Repeat): As per SEC's Directive No. SEC/CMRRCD/2009-193/97 dated January 16, 2011, trading of the shares of Orion Infus
(Repeat): As per SEC's Directive No. SEC/CMRRCD/2009-193/97 dated January 16, 2011, trading of the shares of Orion Infusion Ltd. has been transferred from the OTC Market to the Main Market of DSE for transaction with effect from 23.01.11 under "A" category, as the securities of this company have been declared as eligible for dematerialization. DSE Trading Code for Orion Infusion Ltd. is "ORIONINFU", DSE Company Code # 18472, Face Value Tk. 100.00 each, Market Lot 20 shares and Open price is Tk. 789.25.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.